CAS Bioactivity

Bioactivity data—SAR and ADMET—for performing early analysis in the drug discovery process to eliminate unlikely candidates before expensive clinical trials

Deep content to explore how modifying a drug’s structure and concentration will change its efficacy and safety

Data extracted from journals, patents, public databases, and other publications, enhanced and organized by CAS’s world-renowned scientists

Coverage of all known human targets and thousands more across biological organisms to facilitate the discovery of novel targets for therapeutic intervention

Millions of pharmacokinetic observations, made searchable with standardized values and units and connected with other relevant information

Indexed toxicity values aligned to known substances and structures to help gauge the safety of unique compounds